SHYNDEC(SH:600420) Ge Long Hui A P P·2025-09-22 09:06Core Viewpoint - The company Guoyao Modern (600420.SH) has received approval from the National Medical Products Administration for its subsidiary Guoyao Group Rongsheng Pharmaceutical Co., Ltd. to expand the specifications of its Vitamin B6 injection and pass the consistency evaluation for generic drug quality and efficacy [1] Group 1: Company Developments - Guoyao Modern's subsidiary has been granted a drug approval notice for Vitamin B6 injection, allowing for increased specifications [1] - The approval includes the issuance of a drug approval number, indicating regulatory compliance and market readiness [1] Group 2: Product Information - Vitamin B6 injection is indicated for the prevention and treatment of Vitamin B6 deficiency, including conditions such as isoniazid poisoning, pregnancy-related issues, radiation sickness, and chemotherapy-induced vomiting [1] - The product is also used for total parenteral nutrition and to address nutritional deficiencies due to inadequate intake or progressive weight loss [1] - Additional indications include situations requiring increased Vitamin B6 intake and congenital Vitamin B6 dependency syndrome in newborns [1]